Search for: "Pfizer, Inc "
Results 1241 - 1260
of 1,505
Sort by Relevance
|
Sort by Date
28 Nov 2008, 12:49 pm
victories in fight for European BRCA patents (Holman's Biotech IP Blog) Europe: European Commission proposes strategy for dealing with rare diseases (Pharmacapsules @ Gowlings) US: Former House Ways and Means Economist claims 7-year data exclusive period is sufficient (Patent Docs) US: Medco predicts follow-on biologics regulatory pathway by 2011 (Patent Docs) US: Even after patent has expired, District Court has jurisdiction to set exclusivity date: In re Omeprazole Patent Litigation… [read post]
24 Nov 2008, 2:00 pm
Pfizer, Inc., no. [read post]
21 Nov 2008, 5:49 am
Pfizer Ltd. is the UK operating unit of Pfizer, Inc. [read post]
20 Nov 2008, 9:34 pm
Pfizer, Inc. [read post]
20 Nov 2008, 2:00 pm
Pfizer, Inc., no. [read post]
19 Nov 2008, 3:15 pm
And while we're on the subject of health care, death and the MVNHS ©, regular reader and commenter Scott M tips us to this gem:"Jack Rosser's doctor says taking Pfizer Inc.'s Sutent cancer drug may keep him alive long enough to see his 1-year-old daughter, Emma, enter primary school. [read post]
18 Nov 2008, 12:39 am
Pfizer, Inc. [read post]
17 Nov 2008, 2:00 pm
Pfizer, Inc., no. [read post]
31 Oct 2008, 4:13 am
Since the drug -- sold in the United States by Pfizer Inc. under the brand name Chantix -- was approved in 2006, it has been linked to 3,325 serious injuries and 112 deaths. [read post]
24 Oct 2008, 3:19 pm
Pfizer Inc. said it agreed earlier this week to pay $894 million to settle most Celebrex and Bextra claims. [read post]
23 Oct 2008, 5:14 pm
He Washington state has settled with Pfizer Inc. in a suit over Pfizer's marketing practices. [read post]
23 Oct 2008, 10:31 am
" According to the AP (10/22, Tanner), other "drugs under examination are Genentech Inc.'s psoriasis drug Raptiva (efalizumab), which just last week the Food and Drug Administration (FDA) warned may contribute to a life-threatening brain illness and infections; and Exubera, an inhaled insulin product, linked with lung cancer risks," which "Pfizer Inc. stopped selling...last year. [read post]
22 Oct 2008, 5:37 pm
Pfizer Inc. has agreed to pay $894 million to settle personal injury and consumer fraud claims involving pain medications Bextra and Celebrex. [read post]
20 Oct 2008, 6:47 am
Reaching an $894 million deal, drug giant Pfizer Inc has settled most of its lawsuits over the withdrawal of its pain reliever Bextra which has been linked to an elevated risk of heart attacks and strokes. [read post]
17 Oct 2008, 1:59 pm
In a long expected move, Pfizer Inc agreed in principle yesterday to pay $894 million to settle litigation related to it's painkillers Celebrex and Bextra. [read post]
17 Oct 2008, 12:54 pm
Company Will Pay $745 Million In Settlements To Conclude 90% Of These Lawsuits (Posted by Tom Lamb at DrugInjuryWatch.com) An October 17, 2008 Wall Street Journal (WSJ) article, "Pfizer to Settle Celebrex and Bextra Suits", broke the news and provided the details: Pfizer Inc. has agreed in principle to pay $894 million to settle litigation related to its painkillers Celebrex and Bextra. [read post]
8 Oct 2008, 11:50 am
Pfizer, Inc., 153 S.W.3d 758, 762 (Ky. 2004) (not a holding, but dictum suggesting broad comment k application).Louisiana: Kinney v. [read post]
3 Oct 2008, 10:06 am
PFIZER, INC., and PHARMACIA CORPORATION, CIVIL ACTION NO. 03-11084-PBS was reinstated and "Defendants' motion to dismiss is DENIED with respect to allegations of false claims for off-label pediatric uses. [read post]
2 Oct 2008, 12:36 pm
Danek Medical, Inc., 1999 WL 1054864, *6 (M.D. [read post]
2 Oct 2008, 7:01 am
PFIZER, INC., and PHARMACIA CORPORATION, CIVIL ACTION NO. 03-11084-PBS was reinstated and "Defendants' motion to dismiss is DENIED with respect to allegations of false claims for off-label pediatric uses. [read post]
